Ji Joo Lee

Dr. Ji Joo Lee

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJi Joo Lee
Ji Joo Lee
YCYoung June Choe
Young June Choe
HJHyeongseop Jeong
Hyeongseop Jeong
MKMoonsu Kim
Moonsu Kim
SKSeonggon Kim
Seonggon Kim
YPYoung-Joon Park
Young-Joon Park
Lee JJ, et al. J Korean Med Sci. 2021 Dec;36(50):e346. https://doi.org/10.3346/jkms.2021.36.e346

31 December 2022 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
HPHanul Park
Hanul Park
YPYoung-Joon Park
Young-Joon Park
HLHye Young Lee
Hye Young Lee
MYMi Yu
Mi Yu
YSYeong-Jun Song
Yeong-Jun Song
YKYeonjung Kim
Yeonjung Kim
Objectives: On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir+ritonavir) as a treatment method that could reduce the risk of hospitalization or death for patients with confirmed coronavirus disease 2019 (COVID-19).Methods: From February 6, 2022 to April 2, 2022, the incidence of COVID-19 and the effects of treatment with Paxlovid were analyzed in 2,241 patients and workers at 5 long-term care facilities during the outbreak of the Omicron variant of severe acute respiratory syndrome coronavirus 2 in South Korea.Results: The rate of severe illness or death in the group given Paxlovid was 51% lower than that of the non-Paxlovid group (adjusted risk ratio [aRR], 0.49; 95% confidence interval [CI], 0.24−0.98). Compared to unvaccinated patients, patients who had completed 3 doses of the vaccine had a 71% reduced rate of severe illness or death (aRR, 0.29; 95% CI, 0.13−0.64) and a 65% reduced death rate (aRR, 0.35; 95% CI, 0.15−0.79).Conclusion: Patients given Paxlovid showed a lower rate of severe illness or death and a lower fatality rate than those who did not receive Paxlovid. Patients who received 3 doses of the vaccine had a lower rate of severe illness or death and a lower fatality rate than the unvaccinated group.

30 September 2025 in Western Pacific Surveillance and Response Journal
Verified
Journal Article
Open access
PDF file
SKSeontae Kim
Seontae Kim
JLJia Lee
Jia Lee
JOJiyoung Oh
Jiyoung Oh
JLJi Joo Lee
Ji Joo Lee
GKGeehyuk Kim
Geehyuk Kim
STSangwoo Tak
Sangwoo Tak
In 2023, the Republic of Korea’s Korea Disease Control and Prevention Agency (KDCA) enhanced its event-based surveillance practices by using the World Health Organization’s (WHO) Epidemic Intelligence from Open Sources (EIOS) to actively screen and share information about potential public health threats to the country. This report describes the preliminary assessment of the results of implementing these enhanced event-based surveillance activities from June to October 2023. During this period, 425 (0.4%) events were detected globally by the KDCA from 99 945 media articles, with the highest frequency reported in Asia (185, 43.5%) and North America (81, 19.1%). The most frequently reported diseases or conditions were dengue fever (111, 26.1%) and mpox (32, 7.5%). Eight events were detected early by the KDCA using EIOS before being officially listed on WHO’s Event Information Site (EIS) or in Disease Outbreak News (DON), with an average interval of 20 days (range: 5–41) between the detection date and posting on EIS or DON. Thus, EIOS is efficient in aiding early detection of potential public health threats at the national level. This finding highlights the importance of sustaining international cooperation and support to enhance surveillance capabilities in resource-limited settings and expanding the scope of EIOS, including by incorporating additional sources and sources in additional languages, reducing noise. However, as the current report is based on a descriptive analysis, in the future a systematic evaluation of event-based surveillance using EIOS to identify relevant attributes will need to be conducted.

1 January 2023 in Infection & Chemotherapy
Verified
Journal Article
Open access
HLHye Young Lee
Hye Young Lee
YPYoung-Joon Park
Young-Joon Park
MYMi Yu
Mi Yu
HPHanul Park
Hanul Park
JLJi Joo Lee
Ji Joo Lee
SLSang Eun Lee
Sang Eun Lee
Lee HY, et al. Infect Chemother. 2023 Sep;55:e41. https://doi.org/10.3947/ic.2023.0059

1 January 2025 in Infection & Chemotherapy
Verified
Journal Article
Open access
HLHye Young Lee
Hye Young Lee
YPYoung-Joon Park
Young-Joon Park
SLSang Eun Lee
Sang Eun Lee
JLJi Joo Lee
Ji Joo Lee
JCJihyun Choi
Jihyun Choi
JMJun Young Moon
Jun Young Moon
Lee HY, et al. Infect Chemother. 2025 May;57:e36. https://doi.org/10.3947/ic.2024.0080

18 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
SJSehyuk Jang
Sehyuk Jang
YPYoung-Joon Park
Young-Joon Park
JLJi Joo Lee
Ji Joo Lee
WJWoo-Jin Jeong
Woo-Jin Jeong
This study investigated the causes and risks for infection spread in three psychiatric hospitals in Chung-buk, South Korea, to strategize measures to block transmission and prevent a large-scale epidemic. From December 2020 to January 2021, 358 inpatients of Psychiatric Hospitals A, B, and C were enrolled to identify the epidemiological characteristics of confirmed patients. Epidemic curves and propagation relationships were constructed and a genotype analysis was conducted. The index case inpatient from Hospital A transmitted the infection to patients in Hospitals B and C; the infection was confirmed in 47, 193, and 118 patients in Hospitals A, B, and C, respectively. The patient characteristics hampered communication and the close identification of symptom onset. The incidence rate was 10 (2.9%) among employees and 348 (35.8%) among inpatients. The relative risk was 12.1 (95% CI: 6.6–22.5) times higher among inpatients than employees. Next-generation sequencing confirmed the probable infection source as a genotype identical to that of two different outbreaks, although the infection spread was undetermined. Direct risk factors emerged from patient characteristics, wherein cohort isolation was meaningless due to uncontrolled communication. Indirect risk factors included hospital-specific problems due to external factors (non-patient system deficiencies or employee negligence). Prior inspections, a confirmation of non-infection, and institutional emergent measures are needed.